Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology

Managing Endocrine Complications

At a Glance

Managing APS-1 requires lifelong, coordinated hormone replacement and monitoring. Calcium and vitamin D treatment must protect kidney health, while adrenal insufficiency needs sick-day planning and emergency hydrocortisone; thyroid and sex hormones also require specialist guidance.

Managing the endocrine (hormone-producing) complications of APS-1 (APECED) requires a lifelong commitment to replacing the specific hormones your body can no longer produce on its own [1][2]. Because these hormone failures often happen one after another over many years, your care team must provide consistent monitoring to catch new issues before they become emergencies [3].

Hypoparathyroidism: Balancing Calcium and Kidney Health

Hypoparathyroidism—an immune attack on the parathyroid glands—is one of the most common features of APS-1 [4]. Without parathyroid hormone (PTH), your body cannot maintain healthy levels of calcium in the blood [5].

  • Conventional Treatment: Standard care involves taking oral calcium supplements and active vitamin D (such as calcitriol or alfacalcidol) [5]. The goal is to keep your blood calcium in the “low-normal” range—high enough to prevent symptoms like tingling or muscle cramps, but low enough to protect your kidneys [6].
  • Renal Risks: A major challenge of this treatment is hypercalciuria (too much calcium in the urine), which can lead to nephrocalcinosis (calcium deposits in the kidneys), kidney stones, and eventual kidney damage [7][8]. Regular urine tests and kidney monitoring are essential parts of your care [7].
  • The Malabsorption Factor: Many people with APS-1 also have gastrointestinal issues like autoimmune enteropathy, which makes it very difficult for the body to absorb oral calcium and vitamin D [9]. If your calcium levels fluctuate wildly, your doctor should investigate your gut health [10].
  • PTH Therapies: For some, doctors may prescribe parathyroid hormone replacement. Palopegteriparatide is an approved adult treatment in certain jurisdictions, though pediatric use and availability vary widely [10]. In some settings, PTH(1-34) (teriparatide) is used off-label by specialists [11]. These therapies require careful specialist titration, and not every patient can safely stop oral calcium.

Adrenal Insufficiency (Addison’s Disease)

When the immune system attacks the adrenal glands, they stop producing cortisol (the “stress hormone”) and often aldosterone (which balances salt and blood pressure) [12].

  • Replacement Therapy: Treatment requires glucocorticoids (usually hydrocortisone) to replace cortisol. Many patients also need mineralocorticoids (fludrocortisone) to replace aldosterone, which is assessed clinically through blood pressure, electrolytes, and renin levels [12]. In children, doses must be carefully balanced to ensure normal growth [13].
  • Monitoring: Adrenal replacement is not typically managed by checking random blood cortisol levels. Instead, your team will rely on your symptoms, blood pressure, and specific laboratory markers like renin and electrolytes.
  • Crisis Prevention: Adrenal failure can lead to a life-threatening adrenal crisis during times of physical stress, such as surgery or severe illness [14]. You must follow “sick-day rules”—temporarily increasing your dose—and carry an emergency hydrocortisone injection kit if your doctor prescribes one [15][16].

Reproductive Health and Gonadal Insufficiency

The immune system frequently targets the reproductive organs. In females, this leads to Premature Ovarian Insufficiency (POI), often developing during adolescence (median age 16) [17]. Males can similarly experience testicular failure.

  • Hormone Replacement: Timely sex hormone replacement (estrogen/progesterone or testosterone) is critical for pubertal development, protecting bone health, and supporting overall growth [17][18].
  • Fertility and Family Planning: Gonadal insufficiency makes natural conception difficult. It is vital to seek preconception counseling and high-risk endocrine/obstetric care. Assisted reproductive technologies, such as egg donation, are one possible route for building a family [19].

Thyroid Dysfunction and Type 1 Diabetes

Patients may also develop Hashimoto’s thyroiditis (hypothyroidism) or, in some cases, Type 1 Diabetes [1][20]. Hypothyroidism is managed with a daily levothyroxine pill.

CRITICAL WARNING: If you have untreated or undiagnosed adrenal insufficiency, starting or increasing thyroid hormone replacement without endocrine guidance can precipitate a life-threatening adrenal crisis.

Because your needs will change over time, managing APS-1 is not a “one and done” process. It requires a specialized team that coordinates your care across multiple organ systems and medications [3][2].

Common questions in this guide

How are low calcium levels from APS-1 treated?
Hypoparathyroidism in APS-1 is usually treated with oral calcium and active vitamin D, such as calcitriol or alfacalcidol. Treatment aims to keep blood calcium in a safe low-normal range while reducing symptoms such as tingling and muscle cramps.
Why do people with APS-1 need kidney tests when taking calcium?
Calcium treatment can cause too much calcium to leave the body in the urine, a problem called hypercalciuria. Over time, this can cause kidney deposits, kidney stones, or kidney damage, so clinicians may monitor urine calcium and kidney health.
Could parathyroid hormone treatment help if my calcium is difficult to control?
Some people with APS-1 may be considered for parathyroid hormone replacement, including palopegteriparatide for some adults where it is approved or teriparatide used off-label by a specialist. These medicines require careful dose adjustment, and some patients still need oral calcium.
What is the emergency plan for APS-1 adrenal insufficiency?
People with APS-1 adrenal insufficiency usually need hydrocortisone and sometimes fludrocortisone. During fever, vomiting, injury, surgery, or other physical stress, sick-day rules may require a temporary dose increase; follow your written plan, carry prescribed emergency hydrocortisone, and seek urgent care if you cannot keep medicine down.
Can thyroid medicine be dangerous if adrenal insufficiency is untreated?
Yes. Starting or increasing levothyroxine before untreated adrenal insufficiency is addressed can trigger a life-threatening adrenal crisis. Thyroid treatment should be started or adjusted with guidance from an endocrinology team when adrenal function is uncertain.
How can APS-1 affect puberty and fertility?
APS-1 can cause the ovaries or testes to stop making enough sex hormones. Estrogen and progesterone or testosterone replacement may support puberty, growth, and bone health, while fertility planning may require preconception counseling and assisted reproductive options.
Can digestive problems change how calcium treatment works in APS-1?
Autoimmune enteropathy and other gastrointestinal problems can reduce absorption of oral calcium and vitamin D. New digestive symptoms or large swings in calcium levels should prompt a discussion with the endocrinology team about evaluating the gut and adjusting treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my (or my child's) current urinary calcium-to-creatinine ratio, and how often should we screen for kidney stones or nephrocalcinosis?
  2. 2.Given the difficulty in managing my calcium levels, could I be a candidate for PTH replacement therapy like palopegteriparatide?
  3. 3.Do we have a written 'sick day' plan and an emergency injection kit for adrenal crisis, and can you demonstrate how to use the injectable hydrocortisone?
  4. 4.At what age should we begin monitoring hormone levels to screen for premature ovarian or testicular insufficiency?
  5. 5.Does the presence of gastrointestinal symptoms mean we need to adjust my oral calcium and vitamin D doses due to malabsorption?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?

    Fierabracci A, Lanzillotta M, Vorgučin I, et al.

    Italian journal of pediatrics 2021; (47(1)):126 doi:10.1186/s13052-021-01075-8.

    PMID: 34078422
  2. 2

    Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

    Ferré EMN, Schmitt MM, Lionakis MS

    Frontiers in pediatrics 2021; (9()):723532 doi:10.3389/fped.2021.723532.

    PMID: 34790633
  3. 3

    Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED): Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, and Management.

    Hamidi M, Kamrani M, Karami S, et al.

    Endocrine, metabolic & immune disorders drug targets 2026; doi:10.2174/0118715303511788260918112249.

    PMID: 42786839
  4. 4

    Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review.

    Sharifinejad N, Zaki-Dizaji M, Tebyanian S, et al.

    Expert review of clinical immunology 2021; (17(8)):807-817 doi:10.1080/1744666X.2021.1925543.

    PMID: 33957837
  5. 5

    Impact of periprocedural subcutaneous parathyroid hormone on control of hypocalcaemia in APS-1/APECED patients undergoing invasive procedures.

    Winer KK, Schmitt MM, Ferre EMN, et al.

    Clinical endocrinology 2021; (94(3)):377-383 doi:10.1111/cen.14335.

    PMID: 32955743
  6. 6

    Review of Hypoparathyroidism.

    Abate EG, Clarke BL

    Frontiers in endocrinology 2016; (7()):172 doi:10.3389/fendo.2016.00172.

    PMID: 28138323
  7. 7

    Renal disorders in Autoimmune Polyendocrinopathy Candidiasis Ectodermal dystrophy (APECED): a systematic review.

    Shafiei M, Hosseini S, Ghadimi S, et al.

    BMC pediatrics 2025; (25(1)):139 doi:10.1186/s12887-025-05458-2.

    PMID: 40000975
  8. 8

    Diverse genetic aetiologies and clinical outcomes of paediatric hypoparathyroidism.

    Kim JH, Shin YL, Yang S, et al.

    Clinical endocrinology 2015; (83(6)):790-6 doi:10.1111/cen.12944.

    PMID: 26384470
  9. 9

    Case Report: Severe Hypocalcemic Episodes Due to Autoimmune Enteropathy.

    Halabi I, Barohom MN, Peleg S, et al.

    Frontiers in endocrinology 2021; (12()):645279 doi:10.3389/fendo.2021.645279.

    PMID: 34194389
  10. 10

    Palopegteriparatide treatment for hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case series and literature update.

    Akers H, Maxey L, Ashley K, et al.

    JBMR plus 2026; (10(9)):ziag114 doi:10.1093/jbmrpl/ziag114.

    PMID: 42614145
  11. 11

    Short-Term PTH(1-34) Therapy in Children to Correct Severe Hypocalcemia and Hyperphosphatemia due to Hypoparathyroidism: Two Case Studies.

    Mishra PE, Schwartz BL, Sarafoglou K, et al.

    Case reports in endocrinology 2016; (2016()):6838626 doi:10.1155/2016/6838626.

    PMID: 27957353
  12. 12

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  13. 13

    Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age.

    Yoo HW

    Annals of pediatric endocrinology & metabolism 2021; (26(3)):149-157 doi:10.6065/apem.2142150.075.

    PMID: 34610702
  14. 14

    Adrenal insufficiency.

    Husebye ES, Pearce SH, Krone NP, Kämpe O

    Lancet (London, England) 2021; (397(10274)):613-629 doi:10.1016/S0140-6736(21)00136-7.

    PMID: 33484633
  15. 15

    [Emergency card, emergency medication, and information leaflet for the prevention and treatment of adrenal crisis (Addison crisis): an Austrian consensus document].

    Pilz S, Krebs M, Bonfig W, et al.

    Journal fur klinische Endokrinologie und Stoffwechsel 2022; (15(1)):5-27 doi:10.1007/s41969-022-00155-2.

    PMID: 35251520
  16. 16

    Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.

    Miller BS, Spencer SP, Geffner ME, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2020; (68(1)):16-25 doi:10.1136/jim-2019-000999.

    PMID: 30819831
  17. 17

    Pubertal development and premature ovarian insufficiency in patients with APECED.

    Saari V, Holopainen E, Mäkitie O, Laakso S

    European journal of endocrinology 2020; (183(5)):513-520.

    PMID: 33107435
  18. 18

    Progressive Impairment of Prepubertal Growth in Children With APECED.

    Saari V, Alanko V, Holopainen E, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(2)):e257-e265 doi:10.1210/clinem/dgae209.

    PMID: 38578980
  19. 19

    Pregnancy Outcome in Women With APECED (APS-1): A Multicenter Study on 43 Females With 83 Pregnancies.

    Laakso S, Holopainen E, Betterle C, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(2)):e528-e537 doi:10.1210/clinem/dgab705.

    PMID: 34570215
  20. 20

    A Patient With AIRE Mutation Who Presented With Severe Diarrhea and Lung Abscess.

    Soyak Aytekin E, Serin O, Cagdas D, et al.

    The Pediatric infectious disease journal 2021; (40(1)):66-69 doi:10.1097/INF.0000000000002887.

    PMID: 33284251

This page explains hormone replacement and monitoring for APS-1, but it is for educational purposes only and does not replace medical advice. Your endocrinology team should tailor treatment, sick-day rules, and emergency plans to you or your child.

Get notified when new evidence is published on Autoimmune polyendocrinopathy type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.